NOV 5, 2018: Certis Oncology’s Dr. Fritz Eilber: This Evidence is the Best that Currently Exists

Fritz Eilber, MD, UCLA Surgery Division of Oncology discusses why he joined the Board of Directors at Certis Oncology. Certis provides Orthotopic PDX (Patient-Derived Xenograft) mouse models for cancer patients.

 

Comments are closed.